HK2 and melanoma: SOX4 regulates melanoma glycolytic metabolism controlling the transcriptional expression of glucose transporter type 1, hexokinase 2, and lactate dehydrogenase A, and activates mTORC1 to promote proliferative signals [99] and cell growth when SOX4 is upregulated by CD147 [100].